SK283354B6 - Proliečivo trovafloxacínu, spôsoby jeho výroby a farmaceutické prostriedky na jeho báze - Google Patents

Proliečivo trovafloxacínu, spôsoby jeho výroby a farmaceutické prostriedky na jeho báze Download PDF

Info

Publication number
SK283354B6
SK283354B6 SK237-98A SK23798A SK283354B6 SK 283354 B6 SK283354 B6 SK 283354B6 SK 23798 A SK23798 A SK 23798A SK 283354 B6 SK283354 B6 SK 283354B6
Authority
SK
Slovakia
Prior art keywords
pii
prodrug
monohydrate
diffraction pattern
theta
Prior art date
Application number
SK237-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK23798A3 (en
Inventor
Timothy Norris
James John Mcgarry
Douglas John Meldrum Allen
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK23798A3 publication Critical patent/SK23798A3/sk
Publication of SK283354B6 publication Critical patent/SK283354B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK237-98A 1995-08-29 1996-07-05 Proliečivo trovafloxacínu, spôsoby jeho výroby a farmaceutické prostriedky na jeho báze SK283354B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29
PCT/IB1996/000653 WO1997008191A1 (en) 1995-08-29 1996-07-05 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin

Publications (2)

Publication Number Publication Date
SK23798A3 SK23798A3 (en) 1999-05-07
SK283354B6 true SK283354B6 (sk) 2003-06-03

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
SK237-98A SK283354B6 (sk) 1995-08-29 1996-07-05 Proliečivo trovafloxacínu, spôsoby jeho výroby a farmaceutické prostriedky na jeho báze

Country Status (35)

Country Link
US (1) US6080756A (de)
EP (1) EP0847400B1 (de)
JP (1) JPH11509188A (de)
KR (1) KR100274736B1 (de)
CN (1) CN1193977A (de)
AP (1) AP639A (de)
AR (1) AR004507A1 (de)
AT (1) ATE208790T1 (de)
AU (1) AU696414B2 (de)
BR (1) BR9610283A (de)
CA (1) CA2230303C (de)
CO (1) CO4480740A1 (de)
CZ (1) CZ291524B6 (de)
DE (1) DE69617027T2 (de)
DK (1) DK0847400T3 (de)
DZ (1) DZ2088A1 (de)
ES (1) ES2164892T3 (de)
GT (1) GT199600061A (de)
HR (1) HRP960396A2 (de)
HU (1) HUP9900226A3 (de)
IL (1) IL122652A (de)
MA (1) MA23965A1 (de)
NO (1) NO309039B1 (de)
NZ (1) NZ310542A (de)
OA (1) OA10670A (de)
PL (1) PL185709B1 (de)
PT (1) PT847400E (de)
RU (1) RU2151152C1 (de)
SK (1) SK283354B6 (de)
TN (1) TNSN96110A1 (de)
TR (1) TR199800340T1 (de)
UA (1) UA48982C2 (de)
WO (1) WO1997008191A1 (de)
YU (1) YU48296A (de)
ZA (1) ZA967281B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) * 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
PL325203A1 (en) 1998-07-06
HRP960396A2 (en) 1998-04-30
CA2230303C (en) 2001-07-24
DE69617027D1 (de) 2001-12-20
AR004507A1 (es) 1998-12-16
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
AP9600854A0 (en) 1996-10-31
JPH11509188A (ja) 1999-08-17
CZ291524B6 (cs) 2003-03-12
AU696414B2 (en) 1998-09-10
US6080756A (en) 2000-06-27
KR19990044231A (ko) 1999-06-25
ATE208790T1 (de) 2001-11-15
RU2151152C1 (ru) 2000-06-20
TR199800340T1 (xx) 1998-06-22
YU48296A (sh) 1998-12-23
DE69617027T2 (de) 2002-03-21
GT199600061A (es) 1998-01-31
NO980863D0 (no) 1998-02-27
HUP9900226A3 (en) 1999-11-29
KR100274736B1 (ko) 2000-12-15
AU6135196A (en) 1997-03-19
HUP9900226A2 (hu) 1999-05-28
AP639A (en) 1998-04-14
NO309039B1 (no) 2000-12-04
NZ310542A (en) 1999-09-29
PT847400E (pt) 2002-03-28
MA23965A1 (fr) 1997-04-01
BR9610283A (pt) 1999-03-16
DK0847400T3 (da) 2002-03-25
CA2230303A1 (en) 1997-03-06
IL122652A0 (en) 1996-08-16
DZ2088A1 (fr) 2002-07-22
EP0847400A1 (de) 1998-06-17
CO4480740A1 (es) 1997-07-09
IL122652A (en) 2000-01-31
CN1193977A (zh) 1998-09-23
WO1997008191A1 (en) 1997-03-06
NO980863L (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
ES2164892T3 (es) 2002-03-01
OA10670A (en) 2000-11-06
CZ55298A3 (cs) 1999-02-17
EP0847400B1 (de) 2001-11-14
ZA967281B (en) 1998-03-02
TNSN96110A1 (fr) 2005-03-15
MX9801665A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
CZ285251B6 (cs) Ureido derivát poly-4-amino-2-karboxy-1-methylové sloučeniny
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
SK280822B6 (sk) Imidazopyridíny, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
FI78087B (fi) Foerfarande foer framstaellning av nya n-dihydrotiazolyl-3-kinolinkarboxamidderivat, vilka har anxiolytisk aktivitet.
SK283354B6 (sk) Proliečivo trovafloxacínu, spôsoby jeho výroby a farmaceutické prostriedky na jeho báze
AU704115B2 (en) Zwitterionic forms of trovafloxacin
EP0549857A1 (de) Chinolone Carbonsäurederivate verwendbar als antibakterielles Mittel
US20040019214A1 (en) Novel ester or amide derivatives
US6066647A (en) Zwitterionic forms of trovafloxacin
MXPA98001665A (en) Polymorphoses of profarmaco of 6-n- (l-ala-l-ala) -trovafloxacin, procedure for its preparation and use of mis
AP788A (en) Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis